ImmunoGen Inc. (IMGN) is primed for evolution with the beta value of 1.42 – Invest Chronicle

ImmunoGen Inc. (IMGN) is primed for evolution with the beta value of 1.42

ImmunoGen Inc. (IMGN) is priced at $10.20 after the most recent trading session. At the very opening of the session, the stock price was $8.13 and reached a high price of $8.30, prior to closing the session it reached the value of $8.08. The stock touched a low price of $7.95.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on February 12, 2021, ImmunoGen Reports Recent Progress and 2020 Financial Results. Top-Line Data from Pivotal SORAYA Trial for Mirvetuximab Soravtansine in Ovarian Cancer Expected in Q3 2021; BLA to be Submitted by Year-End. You can read further details here

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


ImmunoGen Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.85 on 02/12/21, with the lowest value was $6.26 for the same time period, recorded on 01/04/21.

ImmunoGen Inc. (IMGN) full year performance was 54.20%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ImmunoGen Inc. shares are logging 22.45% during the 52-week period from high price, and 423.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.95 and $8.33.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2819841 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ImmunoGen Inc. (IMGN) recorded performance in the market was 25.27%, having the revenues showcasing 33.55% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.52B, as it employees total of 75 workers.

ImmunoGen Inc. (IMGN) in the eye of market guru’s

During the last month, 0 analysts gave the ImmunoGen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 6.15, with a change in the price was noted +5.03. In a similar fashion, ImmunoGen Inc. posted a movement of +132.14% for the period of last 100 days, recording 2,615,187 in trading volumes.

ImmunoGen Inc. (IMGN): Stocks Technical analysis and Trends

Raw Stochastic average of ImmunoGen Inc. in the period of last 50 days is set at 99.84%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 99.69%. In the last 20 days, the company’s Stochastic %K was 84.16% and its Stochastic %D was recorded 79.27%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

If we look into the earlier routines of ImmunoGen Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 25.27%. Additionally, trading for the stock in the period of the last six months notably improved by 109.33%, alongside a boost of 54.20% for the period of the last 12 months. The shares increased approximately by 8.60% in the 7-day charts and went down by 15.26% in the period of the last 30 days. Common stock shares were driven by 33.55% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.